Menu Menu

RYTM    Rhythm Pharmaceuticals Inc    1649904    
Income Statement
Revenue rytm-20241231x10k 130,126,000
Net Income rytm-20241231x10k -260,602,000
Profit Margin -200.27%

Balance Sheet
Current Assets 374,200,000
Assets 392,273,000
Current Liabilities 115,517,000
Liabilities 370,544,000
Equity 21,729,000
Shares Out 61,134,000

Cash Flow Statement
Operating Cash Flow -113,879,000
Investing Cash Flow -48,173,000

Market Analysis
Market Cap 3,320,786,367
Price 53.68
BVPS 0.36
PB 154.95
EPS -4.37
PS 0.75
FCF -162,052,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
2/28 -4.34
Apr May Jun
5/07 -2.35
Jul Aug Sep
8/06 -0.55
Oct Nov Dec
11/11

Find a discrepancy? The most accurate way to find company fundamental data is to view RYTM documents filed with the SEC.


RYTM Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker:



View A List of Tickers





We can also help with your taxes.

Formal Tax

www.formal.tax





(402) 804-8293


Formal Financial App
Google Play - Apple Store

created using: Admin Canvas